Metagenomic next-generation sequencing of alveolar lavage fluid improves the detection of pulmonary infection
- PMID: 40391192
- PMCID: PMC12086621
- DOI: 10.1515/biol-2025-1074
Metagenomic next-generation sequencing of alveolar lavage fluid improves the detection of pulmonary infection
Abstract
This study evaluated the effectiveness of metagenomic next-generation sequencing (mNGS) in detecting pathogens in patients with pulmonary infections, comparing a low-data-volume, human-depleted quantitative (Q) method and a high-data-volume, non-human-depleted pathogen capture engine (PACE) method. A total of 133 patients were enrolled, comprising 59 in a control group (traditional culture) and 74 in an mNGS group (51 Q and 23 PACE). Bronchoalveolar lavage fluid samples were collected for pathogen detection. Mycobacterium tuberculosis was predominantly detected via general mNGS, whereas Candida albicans and Epstein-Barr virus were more frequently identified by PACE and Q, respectively. Among participants, 22.97% had bacterial mono-infections, and 2.70% had viral mono-infections; the most common co-infection involved bacteria and viruses (25.68%). Patients with fever, abnormal white blood cell, neutrophil percentage, and D-dimer levels exhibited higher detection rates. PACE showed consistently high sensitivity (decreasing from 100 to 92% as thresholds became more stringent) and specificity and accuracy that peaked at 100 and 96%, respectively. The Q method maintained 100% sensitivity at the lowest threshold but showed variable specificity (0.52-0.67) and accuracy (71-75%). These findings highlight the need for caution in clinical applications when using low-data-volume, human-depleted approaches, especially for complex pulmonary infection cases.
Keywords: diagnostic methods; metagenomic next-generation sequencing; pathogen detection; pulmonary infection.
© 2025 the author(s), published by De Gruyter.
Conflict of interest statement
Conflict of interest: Authors state no conflict of interest.
Figures




Similar articles
-
Diagnostic value of metagenomic next-generation sequencing of bronchoalveolar lavage fluid for the diagnosis of suspected pneumonia in immunocompromised patients.BMC Infect Dis. 2022 Apr 29;22(1):416. doi: 10.1186/s12879-022-07381-8. BMC Infect Dis. 2022. PMID: 35488253 Free PMC article.
-
Metagenomic next-generation sequencing targeted and metagenomic next-generation sequencing for pulmonary infection in HIV-infected and non-HIV-infected individuals.Front Cell Infect Microbiol. 2024 Aug 19;14:1438982. doi: 10.3389/fcimb.2024.1438982. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39224706 Free PMC article.
-
Improving Suspected Pulmonary Infection Diagnosis by Bronchoalveolar Lavage Fluid Metagenomic Next-Generation Sequencing: a Multicenter Retrospective Study.Microbiol Spectr. 2022 Aug 31;10(4):e0247321. doi: 10.1128/spectrum.02473-21. Epub 2022 Aug 9. Microbiol Spectr. 2022. PMID: 35943274 Free PMC article.
-
Application of metagenomic next-generation sequencing (mNGS) in diagnosing pneumonia of adults.J Infect Dev Ctries. 2023 Nov 30;17(11):1566-1573. doi: 10.3855/jidc.18696. J Infect Dev Ctries. 2023. PMID: 38064390
-
Metagenomic next generation sequencing of bronchoalveolar lavage fluids for the identification of pathogens in patients with pulmonary infection: A retrospective study.Diagn Microbiol Infect Dis. 2024 Sep;110(1):116402. doi: 10.1016/j.diagmicrobio.2024.116402. Epub 2024 Jun 12. Diagn Microbiol Infect Dis. 2024. PMID: 38878340 Review.
References
-
- Adjemian J, Olivier KN, Seitz AE, Holland SM, Prevots DR. NTM infections; A rising global health problem/clinical characteristics and outcomes of patients with non-tuberculous mycobacterial infections at two tertiary academic medical centers. Open Forum Infect Dis. 2021;8(11):ofab466. https://www.ncbi.nlm.nih.gov/pmc/articles/8644936.
-
- Alemu A, Bitew ZW, Worku T, Gamtesa DF. Hepatitis B and C virus infections and associated factors among HIV-positive and HIV-negative tuberculosis patients in public health facilities, Northeast Ethiopia: A comparative cross-sectional study. PLoS One. 2023;18(1):e0279172. https://pubmed.ncbi.nlm.nih.gov/37123386. - PMC - PubMed
-
- Chowdhary A, Sharma C, Meis JF. Candida auris: An emerging fungus that presents a serious global health threat. J Fungi. 2023;9(3):239. https://pubmed.ncbi.nlm.nih.gov/36891046. - PMC - PubMed
-
- Widdifield J, Bernatsky S, Paterson JM, Gunraj N, Thorne JC. Mortality burden associated with all-cause pneumonia among adults with autoimmune inflammatory rheumatic diseases, human immunodeficiency virus infection, and malignancies: a population-based comparative study for informed decision-making in public health policies. BMC Infect Dis. 2020;20(1):203. https://pubmed.ncbi.nlm.nih.gov/32180041. - PubMed
-
- Cureus. The impact of pulmonary rehabilitation in a case of acute respiratory distress syndrome with bronchopneumonia: A case report. Cureus. 2022;14(12):e31583. https://pubmed.ncbi.nlm.nih.gov/36686089. - PMC - PubMed
LinkOut - more resources
Full Text Sources